Product Code: OIA FDA class 1 21 CFR 864.3250

Neonatal Blood Collection Kit And Screening Form (Excludes Hiv Testing)

Pathology

The Neonatal Blood Collection Kit and Screening Form (Excludes HIV Testing) is a convenience kit containing components for collecting blood specimens from newborns along with the associated screening documentation form, used for neonatal metabolic and genetic screening programs, excluding HIV testing. Classified as FDA Class 1 under regulation 21 CFR 864.3250 within the Pathology medical specialty, it is under enforcement discretion per the FDA's May 1997 Convenience Kits Interim Regulatory Guidance and does not require a 510(k). The product code is OIA. It is not flagged as an implant or life-sustaining device.

510(k)s
0
FEI Numbers
8
Registration Numbers
8
Unique Applicants
0
Years Active

Research product code OIA in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
OIA
Device Class
FDA class 1
Regulation Number
864.3250
Medical Specialty
Pathology
Review Panel
CH
Submission Type
7

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

Definition

This product code has been established in accordance with the may 20, 1997, guidance entitled, convenience kits interim regulatory guidance, found at www.Fda.Gov/cdrh/ode/convkit.Html. This type of convenience kit, as listed in the guidance above, is under enforcement discretion, and does not require a premarket notification (510(k)) to market if it meets all criteria in the guidance.

FEI Numbers

This FDA classification entry is associated with 8 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 8 registration numbers. Click on an entry to view related FDA registrations.